AKCEA THERAPEUTICS, INC. Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (3)
- Consulting Agreements (4)
- Retention Agreements (1)
- Separation Agreements (5)
- Severance Agreements (9)
- Consulting Agreement between Louis St. L. ODea and the Company dated July 7, 2020 (Filed With SEC on July 9, 2020)
- Separation Agreement between Louis St. L. ODea and the Company dated July 7, 2020 (Filed With SEC on July 9, 2020)
- Severance Benefit Agreement between William Andrews and the Company dated July 9, 2020 (Filed With SEC on July 9, 2020)
- Michael D. Price Severance Benefit Agreement (Filed With SEC on May 18, 2020)
- Non-Employee Director Compensation Plan (Filed With SEC on May 6, 2020)
- Severance Benefit Agreement between the Company and Robert Dolski dated May 23, 2019 (Filed With SEC on April 29, 2020)
- Separation Agreement between the Company and Michael MacLean entered into on April 4, 2020 (Filed With SEC on April 9, 2020)
- Severance Benefit Agreement between Louis St. L. ODea and the Company dated March 16, 2020 (Filed With SEC on March 20, 2020)
- Retention Agreement between Louis St. L. ODea and the Company dated March 16, 2020 (Filed With SEC on March 20, 2020)
- Severance Benefit Agreement (Filed With SEC on March 11, 2020)
- Akcea Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on March 4, 2020)
- Non-Employee Director Compensation Plan (Filed With SEC on March 2, 2020)
- Alex Howarth Severance Benefit Agreement (Filed With SEC on December 4, 2019)
- Amendment to Consulting Agreement, by and between Akcea Therapeutics, Inc. and Paula Soteropoulos, dated October 30, 2019 (Filed With SEC on November 6, 2019)
- Consulting Agreement, by and between Akcea Therapeutics, Inc. and Paula Soteropoulos, dated September 18, 2019 (Filed With SEC on November 6, 2019)
- Separation Agreement, by and between Akcea Therapeutics, Inc. and Jeffrey M. Goldberg, dated September 18, 2019 (Filed With SEC on November 6, 2019)
- Separation Agreement, by and between Akcea Therapeutics, Inc. and Sarah Boyce, dated September 18, 2019 (Filed With SEC on November 6, 2019)
- Separation Agreement, by and between Akcea Therapeutics, Inc. and Paula Soteropoulos, dated September 18, 2019 (Filed With SEC on November 6, 2019)
- Consulting Agreement, by and between Akcea Therapeutics, Inc. and Jeffrey M. Goldberg, dated September 18, 2019 (Filed With SEC on November 6, 2019)
- Kyle Jenne Severance Benefit Agreement (Filed With SEC on October 23, 2019)
- Akcea - Severance Agreement_McDevitt Damien (Filed With SEC on September 23, 2019)
- Non-Employee Director Compensation Plan (Filed With SEC on March 1, 2019)
- Akcea Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on November 23, 2018)
- Akcea Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on May 7, 2018)
- Akcea Therapeutics, Inc. 2015 Equity Incentive Plan, as amended (Filed With SEC on April 20, 2018)
- Form of Severance Benefit Agreement (Filed With SEC on November 30, 2017)
- AKCEA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 16, 2015 APPROVED BY THE STOCKHOLDERS: DECEMBER 16, 2015 AMENDED BY THE BOARD OF... (Filed With SEC on June 20, 2017)
- AKCEA THERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: DECEMBER 16, 2015 APPROVED BY THE STOCKHOLDERS: DECEMBER 16, 2015 TERMINATION DATE: DECEMBER... (Filed With SEC on March 27, 2017)
